Thomas F. Whayne Jr., MD, PhD

Practice areas

Practice areas

Clinical interests

  • Cardiovascular Disease
  • Cardiovascular Risk Reduction
  • Lipid Management

Thomas F. Whayne Jr., MD, PhD

Biography

Dr. Thomas Whayne offers a few thoughts on the pros and cons of a new class of cholesterol-lowering drugs.

My name is Thomas Whayne; I received my medical degree from the University of Pennsylvania, School of Medicine, Philadelphia. I then completed fellowships at the University of California at San Francisco Medical Center and the University of Toronto Medical Center in Canada.

I am board certified by the American Board of Internal Medicine in Cardiovascular Disease.

Faculty rank

Professor of Medicine

Education

Degree
University of Pennsylvania, School of Medicine, Philadelphia

Residency
New York Hospital-Cornell Medical Center

Fellowship
University of California at San Francisco Medical Center
University of Toronto Medical Center, Toronto, Canada

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Cardiovascular Disease

Cardiovascular Medicine

Internal Medicine Subspecialty Clinic

UK Good Samaritan Medical Office Building
Second Floor, Suite 200
125 E. Maxwell St.
Lexington KY 40508-2678

Call 859-257-1000

Parking is available at the Good Samaritan Medical Plaza Parking Lot (on site).

Directions to UK Good Samaritan Medical Office Building Parking »


Insurance information

Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers »

Referral form for physicians »

 
  1. Whayne TF, J. "Prevention of Carotid Artery Atherosclerosis: What is the Evidence?" Angiology 68, 8 (2017): 661-668.
    View in: PubMed
  2. Abolbashari, M.;Macaulay, T.E.;Whayne, T.F.;Mukherjee, D.;Saha, S. "Polypharmacy in Cardiovascular Medicine: Problems and Promises!" Cardiovascular & hematological agents in medicinal chemistry (2017): 
    View in: PubMed
  3. Whayne TF, J. "In Memoriam: James M. Felts, PhD." Journal of clinical lipidology (2017): 
    View in: PubMed
  4. Whayne, T.F. "Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving." Current vascular pharmacology (2017): 
    View in: PubMed
  5. Whayne TF, J. "Is There an Ideal Low-Density Lipoprotein Cholesterol Level? Confusion regarding Lipid Guidelines, Low-Density Lipoprotein Cholesterol Targets, and Medical Management." The International journal of angiology : official publication of the International College of Angiology, Inc 26, 2 (2017): 73-77. 
    View in: PubMed
  6. Fisher, M.B.;Messerli, A.;Whayne TF, J. "Characteristics, Management, and Results of Out-of-Hospital Cardiac Arrest (OHCA) With or Without ST-Segment Elevation Myocardial Infarction (STEMI)." Angiology (2017): 3319717709686.
    View in: PubMed
  7. Whayne TF, J.;Morales, G.X.;Darrat, Y.H. "Clinical Aspects of Systemic Inflammation and Arrhythmogenesis, Especially Atrial Fibrillation." Angiology (2017): 3319717721399. 
    View in: PubMed
  8. Whayne TF, J. "PCSK9 inhibitors in the current management of atherosclerosis." Archivos de cardiologia de Mexico 87,1 (2017): 43-48. 
    View in: PubMed
  9. Whayne, T.F. "Low-Density Lipoprotein Cholesterol (LDL-C): How Low?" Current vascular pharmacology 15, 4 (2017):374-379. 
    View in: PubMed
  10. Wells, G.;Whayne TF, J. "Prognosis for Women With Multivessel Coronary Artery Disease." Angiology 67, 8 (2016):705-8. 
    View in: PubMed
  11. Whayne TF, J. "Editorial : Scoring and Other Assessments of Plaque Morphology and Pathology" Angiology 67, 10(2016): 889-893. 
    View in: PubMed
  12. Saha, S.P.;Whayne TF, J. "Coenzyme Q-10 in Human Health: Supporting Evidence?" Southern medical journal 109, 1(2016): 17-21. 
    View in: PubMed
  13. Whayne TF, J. "Guideline Confusion for the Clinician." Angiology 67, 1 (2016): 5-9. 
    View in: PubMed
  14. Whayne TF, J. "Renal Iodine Dye Risk, Age, and the Acute Coronary Syndrome." Angiology 67, 2 (2016): 107-12.
    View in: PubMed
  15. Whayne TF, J. "New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines." Annals of internal medicine 165, 11 (2016): 827. [PubMed
  16. Mukherjee, D.;Whayne, T.F. "Editorial (Thematic Issue: Sex, Environment, Physical Activity, Diet, and Obesity in Cardiovascular Disease Risk)." Current vascular pharmacology 14, 5 (2016): 406-408. 
    View in: PubMed
  17. Whayne TF, Mukherjee D. Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes. Curr Vasc Pharmacol. 2016 Jul 22.
    View in: PubMed
  18. Whayne TF, Saha SP, Mukherjee D. Antioxidants in the Practice of Medicine; What Should the Clinician Know? Cardiovasc Hematol Disord Drug Targets. 2016 Jun 13.
    View in: PubMed
  19. Whayne TF. Multiple Coronary Artery Interventions. Angiology. 2016 May;67(5):427-30.
    View in: PubMed
  20. Whayne TF. Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia. Am J Cardiovasc Drugs. 2016 Apr;16(2):83-92.
    View in: PubMed
  21. Whayne TF. Statin Intolerance From a Clinician's Perspective. Angiology. 2016 Mar;67(3):205-7.
  22. Whayne TF, Maulik N. Nutrition and the healthy heart with an exercise boost. Can J Physiol Pharmacol. 2012 Aug; 90(8):967-76. PMID: 22812658.
    View in: PubMed
  23. Whayne TF. Atherosclerosis: current status of prevention and treatment. Int J Angiol. 2011 Dec; 20(4):213-22. PMID: 23204822.
    View in: PubMed
  24. Saha SP, Whayne TF, Mukherjee DP. Current management of peripheral vascular disease: where is the evidence? Cardiovasc Hematol Agents Med Chem. 2011 Apr 1; 9(2):128-36. PMID: 21434864.
    View in: PubMed
  25. Whayne TF. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators. Angiology. 2011 Jul; 62(5):415-21. PMID: 21421631.
    View in: PubMed
  26. Whayne TF. [Problems with statins and the marketing of these medications]. Rev Med Chil. 2010 Apr; 138(4):511-4. PMID: 20668802.
    View in: PubMed
  27. Whayne TF. What should medical practitioners know about the role of alternative medicines in cardiovascular disease management? Cardiovasc Ther. 2010 Apr; 28(2):106-23. PMID: 20398100.
    View in: PubMed
  28. Salters CR, Bailey AL, Whayne TF. Current treatment of heart failure in the USA. Expert Rev Cardiovasc Ther. 2010 Feb; 8(2):279-90. PMID: 20136614.
    View in: PubMed
  29. Whayne TF. Concerns about heparin therapy for hypertriglyceridemia. Arch Intern Med. 2010 Jan 11; 170(1):108-9; author reply 109. PMID: 20065209.
    View in: PubMed
  30. Whayne TF. Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review. Int J Angiol. 2010; 19(3):e96-9. PMID: 22477621.
    View in: PubMed
  31. Saha SP, Whayne TF, Mukherjee D. Evidence-based management of carotid artery disease. Int J Angiol. 2010; 19(1):e21-4. PMID: 22477570.
    View in: PubMed
  32. Saha SP, Whayne TF. Cardiovascular care: a challenge for Kentucky. J Ky Med Assoc. 2009 Aug; 107(8):295-7. PMID: 19777939.
    View in: PubMed
  33. Whayne TF. In defense of the metabolic syndrome. J Clin Lipidol. 2009 Aug; 3(4):247-9. PMID: 21291820.
    View in: PubMed
  34. Whayne TF. High-density lipoprotein cholesterol: current perspective for clinicians. Angiology. 2009 Oct-Nov; 60(5):644-9. PMID: 19240106.
    View in: PubMed
  35. Abascal VM, Zielke JC, Spady SD, Mason JW, Whayne TF. Synopsis of an epidemiologic study of a Kentucky county in the Coronary Valley. J Ky Med Assoc. 2008 Nov; 106(11):527-31. PMID: 19058478.
    View in: PubMed
  36. Whayne TF. Is there a problem with ezetimibe or just ENHANCEd hype? Angiology. 2008 Dec-2009 Jan; 59(6):661-3. PMID: 18796445.
    View in: PubMed
  37. Whayne TF. Nonprescription statins: not ready for prime time. Am J Cardiol. 2008 Mar 1; 101(5):745-6; author reply 746. PMID: 18308034.
    View in: PubMed
  38. Whayne TF. A viewpoint on statin effects - benefits and problems. Int J Angiol. 2008; 17(4):178-80. PMID: 22477445.
    View in: PubMed
  39. Whayne TF. Evaluation critique of state of the art dyslipidemia management in general and with a special emphasis on the Indian population. Indian Heart J. 2007 May-Jun; 59(3):218-25. PMID: 19124929.
    View in: PubMed
  40. Saha SP, Bhalla DK, Whayne TF, Gairola C. Cigarette smoke and adverse health effects: An overview of research trends and future needs. Int J Angiol. 2007; 16(3):77-83. PMID: 22477297.
    View in: PubMed
  41. Whayne TF. Coronary atherosclerosis, low-density lipoproteins and markers of thrombosis, inflammation and endothelial dysfunction. Int J Angiol. 2007; 16(1):12-6. PMID: 22477242.
    View in: PubMed
  42. Whayne TF, Zielke JC, Dickson LG, Winters JL. State of the art treatment of the most difficult low density lipoprotein (LDL) cholesterol problems: LDL apheresis. J Ky Med Assoc. 2002 Dec; 100(12):535-8. PMID: 12522946.
    View in: PubMed
  43. Whayne TF, Zielke JC. Problems with the new Adult Treatment Panel III guidelines. Prev Cardiol. 2002; 5(2):91. PMID: 11986555.
    View in: PubMed
  44. Whayne TF, Zielke JC. Triglyceride level: a predictive risk factor for atherosclerosis? Arch Intern Med. 2001 Jan 22; 161(2):295-6. PMID: 11176752.
    View in: PubMed
  45. Whayne TF, Zielke JC. Reduction of cholesterol in Kentucky--a state at high risk. J Ky Med Assoc. 2000 Jun; 98(6):248-53. PMID: 10870339.
    View in: PubMed
  46. Whayne TF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis. 1981 Jun; 39(3):411-24. PMID: 6942843.
    View in: PubMed
  47. Imaizumi T, Chandraratna PA, Whayne TF, Schechter E, Bhatia SK. Transmural myocardial infarction with the prolapsing mitral-leaflet syndrome and normal coronary arteries. Arch Intern Med. 1978 Sep; 138(9):1354-5. PMID: 686924.
    View in: PubMed
  48. Leier CV, Schaal SF, Leighton RF, Whayne TF. Heart block in alcoholic cardiomyopathy. Arch Intern Med. 1974 Oct; 134(4):766-8. PMID: 4413642.
    View in: PubMed
  49. Whayne TF, Witiak DT. A comparative study of the inhibitory activity of clofibrate and related an alogs on lipoprotein lipase in vitro. J Med Chem. 1973 Mar; 16(3):228-31. PMID: 4733102.
    View in: PubMed
  50. Whayne TF, Smith NT, Eger EI, Stoelting RK, Whitcher CE. Reflex cardiovascular responses to simulated diving. Angiology. 1972 Sep; 23(8):500-8. PMID: 5055664.
    View in: PubMed